Eleven Biotherapeutics Inc (NASDAQ:EBIO) is on the brink of a rebranding transformation. As of tomorrow, this firm will be Eleven no longer, instead assuming …
Eleven Biotherapeutics Inc (NASDAQ:EBIO) shares are jumping up like wildfire today on back of an encouraging Phase 3 trial data preview in bladder …
